Evidence map›Paper›PMID 36516368›Full record

SynthesisJCO clinical cancer informatics2022

Transportability Methods for Time-to-Event Outcomes: Application in Adjuvant Colon Cancer Trials.

Shuozhi Zuo, Kevin P Josey, Sridharan Raghavan, Fan Yang, Elizabeth Juaréz-Colunga, Debashis Ghosh

Abstract readMeta-Analysis
In one paragraph

Synthesis in JCO clinical cancer informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A Review of Methods for Research Synthesis.Statistics in medicine · 2025
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuozhi ZuoDepartment of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO.
Kevin P JoseyDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.ORCID 0000-0003-2490-6272
Sridharan RaghavanDivision of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.ORCID 0000-0003-0643-4873
Fan YangYau Mathematical Sciences Center, Tsinghua University, Beijing, China.ORCID 0000-0003-3671-4745
Elizabeth Juaréz-ColungaDepartment of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO.
Debashis GhoshDepartment of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO.ORCID 0000-0001-6618-1316

Funding

GRADUATE TRAINING IN BIOSTATISTICST32ES007142 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Brent Andrew Coull · 1985 to 2026
$11.9M
CSRD VA IK2 CX001907NIEHS NIH HHS T32 ES007142
6 · The paper itself

Abstract

purposeDifferences in the benefits of treatment on 5-year overall survival have been observed in 12 randomized phase III colon cancer adjuvant clinical trials from the ACCENT group. We investigated the reasons for these differences by incorporating the distribution of the observed covariates from each trial. MATERIALS AND

methodsWe applied state-of-the-art transportability methods on the basis of causal inference, and compared them with a conventional meta-analysis approach to predict the treatment effect for the target population. Prediction errors were defined to evaluate whether the identifiability conditions necessary for causal inference were satisfied among the 12 trials, and to measure the performance of each method.

resultsIn the one-trial-at-a-time transportability analysis, the ranks of prediction errors for the target population were mostly consistent with the discrepancy in treatment effects among the 12 trials across the three models. The overall prediction errors between the leave-one-trial-out transportability method and the conventional individual participant data meta-analysis approach were very similar, and more than 40% lower than the overall prediction errors from the one-trial-at-a-time transportability method.

conclusionThe discrepancy in treatment effects among the 12 trials is unlikely to arise from the choice of model specification or distribution of observed covariates but from the distribution of unobserved covariates or study-level features. The ability to quantify heterogeneity among the 12 trials was greatly reduced in both the leave-one-trial-out transportability method and the conventional meta-analysis approach compared with the one-trial-at-a-time transportability method.

Indexed as

Colonic NeoplasmsHumans

Identifiers

PMID36516368
PMCPMC10166520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.